Avertix to Present at Two Upcoming Investor Conferences in September 2023

EATONTOWN, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — Avertix Medical, Inc. (“Avertix” or the “Company”), a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, today announces that Company management will participate in two investor conferences in the month of September 2023:

  • Sidoti Small Cap Conference on September 20-21, 2023
  • Cantor Fitzgerald Global Healthcare Conference on September 26-28, 2023

About Sidoti Small Cap Conference

Avertix’s President & Chief Executive Officer, Tim Moran, and EVP & Chief Financial Officer, Philip Tom, will deliver a presentation during the Sidoti Small Cap Conference, which will be held on September 20-21, 2023, virtually.

The presentation is scheduled for Wednesday, September 20, 2023, at 3:15 pm Eastern Time and will be accessible via a live webcast, here. The webcast replay will be available after the conclusion of the live presentation on the Investor Relations section of the Company’s website.

About Cantor Fitzgerald Global Healthcare Conference

Avertix’s President & Chief Executive Officer, Tim Moran, and EVP & Chief Financial Officer, Philip Tom, will engage in a fireside chat during the Cantor Fitzgerald Global Healthcare Conference on September 26-28, 2023 at the InterContinental Barclay Hotel in New York City.

The fireside chat is scheduled for Wednesday, September 27, 2023, at 8:35 am Eastern Time, and will be accessible via a live webcast, here. The webcast replay will be available after the conclusion of the live presentation on the Investor Relations section of the Company’s website.

About Avertix Medical, Inc.

Avertix is a cutting-edge medical device company offering the first and only FDA-approved Class III implantable device that can detect silent and atypical symptomatic heart attacks in real-time. With a robust portfolio of U.S. patents pertaining to Acute Coronary Syndrome (ACS) events, Avertix is at the forefront of innovation in cardiovascular care and is committed to improving patient outcomes and saving lives through advanced medical technologies. For more information, visit avertix.com.

About The Guardian™ System

The Guardian System is implanted subcutaneously by a cardiologist or electrophysiologist during a low risk, outpatient surgical procedure. The Guardian System’s proprietary algorithm uses machine learning to establish a patient’s baseline, then continuously records the heart’s electrical activity, 24/7, detecting and alerting for shifts in the ST segment, indicative of heart attacks. The Guardian System provides a more effective diagnosis of a life-threatening event when compared to patient symptoms alone. Hear what patients are saying about The Guardian, here.

Contacts

Media Relations
Sean Leous
ICR Westwicke
Sean.Leous@westwicke.com
+1-646-866-4012

Holly Windler
media@avertix.com

Investor Relations
Mike Cavanaugh
ICR Westwicke
Mike.Cavanaugh@westwicke.com
+1-617-877-964

 

Staff

Recent Posts

NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil

Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…

5 hours ago

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. -…

5 hours ago

Replicare Attracts Seasoned Leaders From Surgical Telepresence Space

SAN ANTONIO, July 1, 2024 /PRNewswire/ -- Replicare, a leading innovator in remote surgical telepresence…

5 hours ago

MED-LAB ANNOUNCES NEW NAME, LOOK & BUSINESS EXPANSION

MIAMI, July 1, 2024 /PRNewswire/ -- Med-Lab is excited to announce that it is changing…

5 hours ago

Notice of SysInformation Healthcare Services, LLC Data Security Event Which Affected Atlanta Perinatal Consultants, LLP

ATLANTA, July 1, 2024 /PRNewswire/ -- SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM, is a professional…

5 hours ago

Segmed Unveils New Brand Identity and Introduces Openda, the Next Evolution for Its Insight Platform

Openda: Empowering Healthcare Innovation with Advanced Medical Imaging Data Solutions PALO ALTO, Calif., July 1,…

5 hours ago